US FDA Approves Isembyld For Spinal Muscular Atrophy In Patients Aged 2 Years And Older
SRRK•FDA approval for Isembyld
Sept. 11 (Reuters) - Scholar Rock Holding Corporation (SRRK.O):
- US FDA approves Isembyld for spinal muscular atrophy in patients aged 2 years and older
Further company coverage: SRRK.O
